Matinas BioPharma Holdings IncNYSE American:MTNB
- LAST PRICE0.3985
- TODAY'S CHANGE (%)0.0059 (1.5028%)
- Bid / Lots0.3900/ 54
- Ask / Lots0.4200/ 6
- Open / Previous Close0.3920 / 0.3926
- Day Range
- 52 Week Range
- Volume245,964
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MTNB |
|---|---|---|
| 09:32 ET | 2325 | 0.3922 |
| 09:34 ET | 200 | 0.3922 |
| 09:36 ET | 5100 | 0.3922 |
| 09:38 ET | 200 | 0.3925 |
| 09:41 ET | 100 | 0.3922 |
| 09:43 ET | 200 | 0.393 |
| 09:45 ET | 100 | 0.393 |
| 09:48 ET | 200 | 0.393 |
| 09:50 ET | 200 | 0.393 |
| 09:52 ET | 4932 | 0.4065 |
| 09:54 ET | 100 | 0.393 |
| 09:56 ET | 862 | 0.42 |
| 09:59 ET | 918 | 0.393 |
| 10:01 ET | 100 | 0.393 |
| 10:03 ET | 508 | 0.4126 |
| 10:06 ET | 5000 | 0.4046 |
| 10:08 ET | 200 | 0.4044 |
| 10:10 ET | 1200 | 0.4045 |
| 10:12 ET | 1000 | 0.4023 |
| 10:14 ET | 5900 | 0.393 |
| 10:15 ET | 300 | 0.4088 |
| 10:17 ET | 425 | 0.3922 |
| 10:19 ET | 504 | 0.3922 |
| 10:21 ET | 2095 | 0.3989 |
| 10:24 ET | 1291 | 0.3989 |
| 10:26 ET | 100 | 0.3911 |
| 10:28 ET | 2100 | 0.3911 |
| 10:30 ET | 100 | 0.3911 |
| 10:33 ET | 100 | 0.3921 |
| 10:35 ET | 100 | 0.3921 |
| 10:37 ET | 2100 | 0.399399 |
| 10:39 ET | 200 | 0.3921 |
| 10:42 ET | 1200 | 0.3922 |
| 10:44 ET | 600 | 0.3922 |
| 10:46 ET | 400 | 0.3922 |
| 10:51 ET | 100 | 0.399499 |
| 10:53 ET | 500 | 0.4066 |
| 10:55 ET | 700 | 0.4066 |
| 10:57 ET | 200 | 0.3923 |
| 11:00 ET | 400 | 0.3923 |
| 11:02 ET | 3100 | 0.41 |
| 11:04 ET | 100 | 0.3923 |
| 11:06 ET | 300 | 0.4011 |
| 11:08 ET | 200 | 0.4011 |
| 11:09 ET | 500 | 0.3922 |
| 11:11 ET | 200 | 0.4098 |
| 11:13 ET | 200 | 0.3927 |
| 11:15 ET | 3200 | 0.3922 |
| 11:18 ET | 100 | 0.3922 |
| 11:20 ET | 100 | 0.3927 |
| 11:22 ET | 653 | 0.4013 |
| 11:29 ET | 6000 | 0.4 |
| 11:31 ET | 100 | 0.39265 |
| 11:33 ET | 1700 | 0.39265 |
| 11:36 ET | 100 | 0.3927 |
| 11:51 ET | 700 | 0.3923 |
| 11:56 ET | 100 | 0.3923 |
| 11:58 ET | 10100 | 0.3924 |
| 12:00 ET | 200 | 0.3923 |
| 12:02 ET | 200 | 0.3922 |
| 12:03 ET | 100 | 0.3922 |
| 12:05 ET | 3000 | 0.4 |
| 12:12 ET | 900 | 0.4 |
| 12:14 ET | 100 | 0.3921 |
| 12:20 ET | 100 | 0.3921 |
| 12:21 ET | 100 | 0.3923 |
| 12:23 ET | 100 | 0.3923 |
| 12:25 ET | 100 | 0.3921 |
| 12:27 ET | 20200 | 0.3921 |
| 12:32 ET | 100 | 0.3921 |
| 12:34 ET | 100 | 0.3921 |
| 12:36 ET | 200 | 0.3921 |
| 12:39 ET | 100 | 0.3921 |
| 12:41 ET | 150 | 0.396 |
| 12:43 ET | 100 | 0.3925 |
| 12:45 ET | 100 | 0.3921 |
| 12:48 ET | 1134 | 0.3997 |
| 12:50 ET | 100 | 0.3921 |
| 12:52 ET | 100 | 0.3921 |
| 12:54 ET | 100 | 0.3921 |
| 12:59 ET | 100 | 0.3921 |
| 01:01 ET | 400 | 0.3959 |
| 01:03 ET | 450 | 0.3921 |
| 01:06 ET | 998 | 0.395 |
| 01:08 ET | 100 | 0.3921 |
| 01:15 ET | 350 | 0.3997 |
| 01:17 ET | 8051 | 0.3921 |
| 01:19 ET | 300 | 0.3921 |
| 01:24 ET | 439 | 0.395 |
| 01:28 ET | 5300 | 0.39518 |
| 01:30 ET | 300 | 0.3932 |
| 01:32 ET | 100 | 0.3932 |
| 01:33 ET | 100 | 0.3932 |
| 01:35 ET | 200 | 0.3932 |
| 01:37 ET | 130 | 0.393201 |
| 01:44 ET | 100 | 0.3932 |
| 01:46 ET | 1625 | 0.3932 |
| 01:48 ET | 300 | 0.3931 |
| 01:57 ET | 234 | 0.3931 |
| 02:00 ET | 100 | 0.3921 |
| 02:04 ET | 280 | 0.392 |
| 02:08 ET | 1200 | 0.3921 |
| 02:09 ET | 200 | 0.3922 |
| 02:11 ET | 100 | 0.3922 |
| 02:13 ET | 100 | 0.3922 |
| 02:15 ET | 100 | 0.3922 |
| 02:18 ET | 4600 | 0.3922 |
| 02:20 ET | 300 | 0.393 |
| 02:22 ET | 100 | 0.393 |
| 02:24 ET | 100 | 0.393 |
| 02:26 ET | 200 | 0.393 |
| 02:27 ET | 100 | 0.4078 |
| 02:29 ET | 600 | 0.3924 |
| 02:31 ET | 100 | 0.3924 |
| 02:33 ET | 100 | 0.3924 |
| 02:38 ET | 310 | 0.3924 |
| 02:40 ET | 200 | 0.3925 |
| 02:42 ET | 100 | 0.3925 |
| 02:45 ET | 100 | 0.40005 |
| 02:47 ET | 300 | 0.3925 |
| 02:49 ET | 1725 | 0.3925 |
| 02:54 ET | 100 | 0.3925 |
| 02:58 ET | 1159 | 0.3924 |
| 03:02 ET | 100 | 0.3924 |
| 03:03 ET | 600 | 0.393 |
| 03:05 ET | 100 | 0.393 |
| 03:07 ET | 400 | 0.3935 |
| 03:09 ET | 100 | 0.3935 |
| 03:12 ET | 100 | 0.3935 |
| 03:14 ET | 100 | 0.3935 |
| 03:16 ET | 3450 | 0.4 |
| 03:18 ET | 1700 | 0.393101 |
| 03:20 ET | 100 | 0.393 |
| 03:21 ET | 100 | 0.3931 |
| 03:23 ET | 295 | 0.3966 |
| 03:27 ET | 400 | 0.39485 |
| 03:34 ET | 527 | 0.4001 |
| 03:38 ET | 300 | 0.3966 |
| 03:39 ET | 400 | 0.3931 |
| 03:41 ET | 5304 | 0.4108 |
| 03:43 ET | 16305 | 0.3995 |
| 03:45 ET | 8100 | 0.40099 |
| 03:48 ET | 7100 | 0.39635 |
| 03:50 ET | 18364 | 0.39705 |
| 03:52 ET | 6730 | 0.3933 |
| 03:54 ET | 4536 | 0.3987 |
| 03:56 ET | 300 | 0.3932 |
| 03:57 ET | 345 | 0.3932 |
| 03:59 ET | 15534 | 0.3985 |
May 11, 2023
Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023, from 7:30AM ET on Thursday May 11, 2023 by GlobeNewswire
7:30AM ET on Thursday May 11, 2023 by GlobeNewswire
May 10, 2023
BRIEF-Matinas Biopharma Reports Qtrly Loss Per Share $0.03, from 5:15PM ET on Wednesday May 10, 2023 by Thomson Reuters
5:15PM ET on Wednesday May 10, 2023 by Thomson ReutersMatinas BioPharma Reports First Quarter 2023 Financial Results and Provides a Business Update, from 4:05PM ET on Wednesday May 10, 2023 by GlobeNewswire
4:05PM ET on Wednesday May 10, 2023 by GlobeNewswire
May 3, 2023
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Update on May 10, 2023, from 7:00AM ET on Wednesday May 03, 2023 by GlobeNewswire
7:00AM ET on Wednesday May 03, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Matinas BioPharma Holdings Inc | 85.3M | -4.2x | --- |
Sol Gel Technologies Ltd | 88.4M | -4.1x | --- |
vTv Therapeutics Inc | 87.8M | -3.9x | --- |
Lyra Therapeutics Inc | 86.0M | -2.5x | --- |
Collplant Biotechnologies Ltd | 86.9M | -4.9x | --- |
Clene Inc. | 82.3M | -2.5x | --- |
Company Information
Matinas BioPharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform) to maximize global clinical impact and patient access. The Company’s lead anti-fungal product candidate, MAT2203, is an application of its LNC Platform to a broad spectrum and potent anti-fungal drug called amphotericin B. Its second clinical-stage LNC-based product candidate is MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin, which may be used to treat different types of multidrug-resistant bacteria, including NTM, as well as various multidrug-resistant gram-negative and intracellular bacterial infections. It also has internal discovery programs ongoing in the formulation and delivery of small oligonucleotides, namely antisense oligonucleotides (ASOs) and silencing or short interfering RNAs (siRNAs).
Contact Information
- Headquarters
- Suite 302, 1545 Route 206 SouthBEDMINSTER, NJ, United States 07921
- Phone
- 908-443-1860
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Eric Ende
- President, Chief Executive Officer, Director
- Jerome Jabbour
- Chief Financial Officer
- Keith Kucinski
- Chief Technology Officer
- Hui Liu
- Chief Scientific Officer
- Raphael Mannino
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $85.3M |
|---|---|
Revenue (TTM) | $4.3M |
Shares Outstanding | 217.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.02 |
EPS | $-0.09 |
Book Value | $0.17 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 19.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -483.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
